---
figid: PMC9016174__fgwh-03-856316-g0001
figtitle: Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for Endometriosis
organisms:
- NA
pmcid: PMC9016174
filename: fgwh-03-856316-g0001.jpg
figlink: /pmc/articles/PMC9016174/figure/F1/
number: F1
caption: Schematic diagram of VEGF expression by Estradiol (E2) and Estrogen Receptors
  (ERs) through the Wnt/β-catenin signaling pathway. E2 promotes the direct binding
  of ERα to the Estrogen Response Element (ERE) site of the β-catenin promotor, enhancing
  its expression (). E2 also activates the Phosphoinositide 3-kinases (PI3Ks)/AKT
  serine-threonine protein kinase (AKT) axis, which inactivates Glycogen synthase
  kinase (GSK) 3β through phosphorylation. The inhibited β-catenin destruction complex,
  which consists of APC regulator of WNT signaling pathways (APC) and Axis Inhibition
  Protein (AXIN), decreases β-catenin degradation. Accumulated β-Catenin enters the
  nucleus to bind to transcription factor 3/lymphoid enhancing binding factor 1 (TCF3/LEF1),
  enhancing VEGF expression (). ERα and ERβ also directly bind to the VEGF promoter
  region and increase VEGF expression upon E2 activation (–).
papertitle: Endometriosis-Associated Angiogenesis and Anti-angiogenic Therapy for
  Endometriosis.
reftext: Monica S. Chung, et al. Front Glob Womens Health. 2022;3:856316.
year: '2022'
doi: 10.3389/fgwh.2022.856316
journal_title: Frontiers in Global Women's Health
journal_nlm_ta: Front Glob Womens Health
publisher_name: Frontiers Media S.A.
keywords: endometriosis | angiogenesis | estrogen receptors | vascular endothelial
  growth factor | anti-angiogenic therapy
automl_pathway: 0.9595576
figid_alias: PMC9016174__F1
figtype: Figure
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
redirect_from: /figures/PMC9016174__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9016174__fgwh-03-856316-g0001.html
  '@type': Dataset
  description: Schematic diagram of VEGF expression by Estradiol (E2) and Estrogen
    Receptors (ERs) through the Wnt/β-catenin signaling pathway. E2 promotes the direct
    binding of ERα to the Estrogen Response Element (ERE) site of the β-catenin promotor,
    enhancing its expression (). E2 also activates the Phosphoinositide 3-kinases
    (PI3Ks)/AKT serine-threonine protein kinase (AKT) axis, which inactivates Glycogen
    synthase kinase (GSK) 3β through phosphorylation. The inhibited β-catenin destruction
    complex, which consists of APC regulator of WNT signaling pathways (APC) and Axis
    Inhibition Protein (AXIN), decreases β-catenin degradation. Accumulated β-Catenin
    enters the nucleus to bind to transcription factor 3/lymphoid enhancing binding
    factor 1 (TCF3/LEF1), enhancing VEGF expression (). ERα and ERβ also directly
    bind to the VEGF promoter region and increase VEGF expression upon E2 activation
    (–).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ESR1
  - ERAL1
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - CTNNB1
  - AKT1
  - AKT2
  - AKT3
  - APC
  - PROC
  - GSK3B
  - ESR2
  - AXIN1
  - AXIN2
  - HNF4A
  - LEF1
  - TCF7
  - TCF7L1
  - TCF7L2
  - VEGFA
  - VEGFB
  - VEGFC
  - VEGFD
  - PGF
  - era
  - Pi3K21B
  - Pi3K59F
  - Pi3K68D
  - Pi3K92E
  - arm
  - Akt
  - Apc
  - Apc2
  - Axn
  - Fs(3)Apc
  - sgg
  - gskt
  - pan
  - Pvf1
  - Pvf2
  - Pvf3
  - Pvr
---
